Bisphosphonates

EC 35 Pill - yellow capsule-shape

Pill with imprint EC 35 is Yellow, Capsule-shape and has been identified as Risedronate Sodium Delayed-Release 35 mg. It is supplied by Actavis.

Risedronate is used in the treatment of Osteoporosis; Prevention of Osteoporosis; Paget's Disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Risedronate (Risedronate [ ris-ed-roe-nate ])-EC 35-35 mg-Yellow-Capsule-shape

Risedronate
Generic Name: risedronate [ ris-ed-roe-nate ]
Imprint: EC 35
Strength: 35 mg
Color: Yellow
Size: N/A
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Bisphosphonates
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: Edetate disodium, Ferric oxide yellow, Magnesium stearate, Methacrylic acid - ethyl acrylate copolymer (1:1) type a, Polysorbate 80, Microcrystalline cellulose, Silicon dioxide, Sodium starch glycolate type A potato, Stearic acid, Magnesium silicate, Triethyl citrate,
Latest News
Related Drugs